News Spotlight: Zynex (NASDAQ:ZYXI)

Zynex (NASDAQ:ZYXI) stock observed trading -18.63% off 52-week high price. On the other end, the stock has been noted 324.72% away from low price over the last 52-weeks. The stock disclosed a move of 8.62% away from 50 day moving average and 50.21% away from 200 day moving average. Moving closer, we can see that shares have been trading -0.65% off 20-day moving average. It has market cap of $329.71M.

On Oct. 17, 2019, Zynex (NASDAQ:ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, declared that it will host the Company’s 2019 third quarter investor webcast on Tuesday, October 29, 2019 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)

The Company expects to file its 2019 third quarter financial results on Tuesday, October 29, 2019.

About Zynex

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company’s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers.

 The USA based company Zynex moved with change of -4.14% to $10.66 with the total traded volume of 739174 shares in recent session versus to an average volume of 314.34K. The stock was observed in the 5 days activity at -4.31%. The one month performance of stock was 13.89%. ZYXI’s shares are at 37.90% for the quarter and driving a 256.65% return over the course of the past year and is now at 262.59% since this point in 2018.  Right now the stock beta is 0.81. The average volatility for the week and month was at 8.77% and 7.59% respectively. There are 30.93M shares outstanding and 15.81M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *